Clinical trial
Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients
NCT02207153 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- August 31, 2018
- Enrollment
- 217 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endstage renal disease